InvestorsHub Logo
Followers 34
Posts 2585
Boards Moderated 0
Alias Born 01/24/2014

Re: None

Saturday, 11/24/2018 12:48:37 AM

Saturday, November 24, 2018 12:48:37 AM

Post# of 675
Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its product candidates include AM-101, which is in phase III clinical development for the treatment of acute inner ear tinnitus; and AM-111 that is in phase III clinical development for the treatment of acute inner ear hearing loss.